ASP-2998

N/A

Report date: 2026/04/14 20:00:15

Base Information

Drug NameASP-2998

Drug Alias NameASP2998ASP-2998

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionAnti-Trop-2DNA topoisomerase I inhibitorsStimulator of interferon genes agonists

TargetsTumor-associated calcium signal transducer 2DNA topoisomerase IStimulator of interferon genes

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesJapan

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

ATC CodeN/A